Showing results (451-460 of 846) with videos related to
Sort By:
Pageof 85
European Review for Medical and Pharmacological Sciences|January 21, 2014
Tricks for interpreting and making a good report on hydrogen and 13C breath testsG D'Angelo, T A Di Rienzo, F Scaldaferri, et al.Nature Communications|May 5, 2026
Human brain changes after first psilocybin useT Lyons, M Spriggs, L Kerkelä, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 16, 2021
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort studyD F Bavaro, L Diella, C Fabrizio, et al.Journal of Geophysical Research. Atmospheres : JGR|December 4, 2018
The superstatistical nature and interoccurrence time of atmospheric mercury concentration fluctuationsF Carbone, A G Bruno, A Naccarato, et al.Diabetologia|April 25, 2012
Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patientsM Scotto, G Afonso, E Larger, et al.Bioorganic & Medicinal Chemistry Letters|March 18, 2014
Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexantScott D Kuduk, Jason W Skudlarek, Christina N Di Marco, et al.Transplantation Proceedings|April 26, 2016
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-AnalysisF Scaldaferri, S Pecere, V Petito, et al.Circulation. Cardiovascular Interventions|March 16, 2019
Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical PresentationTullio Palmerini, Antonio G Bruno, Martine Gilard, et al.Bioorganic & Medicinal Chemistry Letters|August 26, 2009
Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibilityMichael R Wood, Kathy M Schirripa, June J Kim, et al.Bioorganic & Medicinal Chemistry Letters|May 19, 2015
Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development propertiesScott D Kuduk, Jason W Skudlarek, Christina N DiMarco, et al.Pageof 85